Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multi Center, Open Label Non Inferiority Trial Evaluating the Clinical Adequacy of Intraoperative Tumor Fluorescence With Cytalux™ (Pafolacianine) Across Two Preoperative Administration Windows in Adults Undergoing Surgery for Suspected Lung Cancer or Confirmed Ovarian Cancer

NCT07469202 is registered in ClinicalTrials.gov with On Target Laboratories, LLC as lead sponsor.

NCT NCT07469202
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07469202 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multi Center, Open Label Non Inferiority Trial Evaluating the Clinical Adequacy of Intraoperative Tumor Fluorescence With Cytalux™ (Pafolacianine) Across Two Preoperative Administration Windows in Adults Undergoing Surgery for Suspected Lung Cancer or Confirmed Ovarian Cancer
Lead sponsor
On Target Laboratories, LLC
Phase
Phase 4
Overall status
Not yet recruiting
Start date
August 15, 2026
Completion date
February 28, 2027
Enrollment
106 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cancer in the lung, ovarian cancer